mozobil

Generic: plerixafor

Labeler: sanofi-aventis u.s. llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name mozobil
Generic Name plerixafor
Labeler sanofi-aventis u.s. llc
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

plerixafor 24 mg/1.2mL

Manufacturer
Sanofi-Aventis U.S. LLC

Identifiers & Regulatory

Product NDC 0024-5862
Product ID 0024-5862_fec4102e-2c66-433f-ab6c-7f420b4c3a86
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022311
Listing Expiration 2026-12-31
Marketing Start 2013-09-01

Pharmacologic Class

Established (EPC)
hematopoietic stem cell mobilizer [epc]
Physiologic Effect
increased hematopoietic stem cell mobilization [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00245862
Hyphenated Format 0024-5862

Supplemental Identifiers

RxCUI
828700 828703
UNII
S915P5499N
NUI
N0000178326 N0000178324

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mozobil (source: ndc)
Generic Name plerixafor (source: ndc)
Application Number NDA022311 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 24 mg/1.2mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (0024-5862-01) / 1.2 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

0024-5862-01 1 VIAL, SINGLE-USE in 1 CARTON (0024-5862-01) / 1.2 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

plerixafor (24 mg/1.2mL)

Linked Drug Pages (1)

Mozobil ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "fec4102e-2c66-433f-ab6c-7f420b4c3a86", "openfda": {"nui": ["N0000178326", "N0000178324"], "unii": ["S915P5499N"], "rxcui": ["828700", "828703"], "spl_set_id": ["0ed08d2b-5051-46b2-aa37-1d6275bf9003"], "pharm_class_pe": ["Increased Hematopoietic Stem Cell Mobilization [PE]"], "pharm_class_epc": ["Hematopoietic Stem Cell Mobilizer [EPC]"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0024-5862-01)  / 1.2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "0024-5862-01", "marketing_start_date": "20130901"}], "brand_name": "Mozobil", "product_id": "0024-5862_fec4102e-2c66-433f-ab6c-7f420b4c3a86", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Hematopoietic Stem Cell Mobilizer [EPC]", "Increased Hematopoietic Stem Cell Mobilization [PE]"], "product_ndc": "0024-5862", "generic_name": "PLERIXAFOR", "labeler_name": "Sanofi-Aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mozobil", "active_ingredients": [{"name": "PLERIXAFOR", "strength": "24 mg/1.2mL"}], "application_number": "NDA022311", "marketing_category": "NDA", "marketing_start_date": "20130901", "listing_expiration_date": "20261231"}